| Atrial fibrillation in patients with cryptogenic stroke DJ Gladstone, M Spring, P Dorian, V Panzov, KE Thorpe, J Hall, H Vaid, ... N engl J med 370, 2467-2477, 2014 | 1252 | 2014 |
| Rivaroxaban for Stroke Prevention after Embolic Stroke of Undetermined Source New England Journal of Medicine 378 (23), 2191-2201, 2018 | 718 | 2018 |
| Atrial premature beats predict atrial fibrillation in cryptogenic stroke: results from the EMBRACE trial DJ Gladstone, P Dorian, M Spring, V Panzov, M Mamdani, JS Healey, ... Stroke 46 (4), 936-941, 2015 | 194 | 2015 |
| Association of clinical, imaging, and thrombus characteristics with recanalization of visible intracranial occlusion in patients with acute ischemic stroke BK Menon, FS Al-Ajlan, M Najm, J Puig, M Castellanos, D Dowlatshahi, ... Jama 320 (10), 1017-1026, 2018 | 171 | 2018 |
| Rivaroxaban or aspirin for patent foramen ovale and embolic stroke of undetermined source: a prespecified subgroup analysis from the NAVIGATE ESUS trial SE Kasner, B Swaminathan, P Lavados, M Sharma, K Muir, R Veltkamp, ... The Lancet Neurology 17 (12), 1053-1060, 2018 | 143 | 2018 |
| Canadian Stroke Best Practice Recommendations: Secondary Prevention of Stroke Guidelines, Update 2014 SB Coutts, TH Wein, MP Lindsay, B Buck, R Cote, P Ellis, N Foley, MD Hill, ... International journal of stroke 10 (3), 282-291, 2015 | 126 | 2015 |
| Prospective validation of the ABCD2 score for patients in the emergency department with transient ischemic attack JJ Perry, M Sharma, MLA Sivilotti, J Sutherland, C Symington, A Worster, ... Cmaj 183 (10), 1137-1145, 2011 | 126 | 2011 |
| Reduced blood brain barrier breakdown in P-selectin deficient mice following transient ischemic stroke: a future therapeutic target for treatment of stroke AY Jin, UI Tuor, D Rushforth, J Kaur, RN Muller, JL Petterson, S Boutry, ... BMC neuroscience 11 (1), 1-9, 2010 | 90 | 2010 |
| Patent foramen ovale closure, antiplatelet therapy or anticoagulation therapy alone for management of cryptogenic stroke? A clinical practice guideline T Kuijpers, FA Spencer, RAC Siemieniuk, PO Vandvik, CM Otto, L Lytvyn, ... Bmj 362, 2018 | 87 | 2018 |
| A prospective cohort study of patients with transient ischemic attack to identify high-risk clinical characteristics JJ Perry, M Sharma, MLA Sivilotti, J Sutherland, A Worster, M Émond, ... Stroke 45 (1), 92-100, 2014 | 71 | 2014 |
| Canadian Stroke Best Practice Consensus Statement: Acute Stroke Management during pregnancy NNN Ladhani, RH Swartz, N Foley, K Nerenberg, EE Smith, G Gubitz, ... International Journal of Stroke 13 (7), 743-758, 2018 | 57 | 2018 |
| Rural-urban differences in stroke risk factors, incidence, and mortality in people with and without prior stroke: The CANHEART stroke study MK Kapral, PC Austin, G Jeyakumar, R Hall, A Chu, AM Khan, AY Jin, ... Circulation: Cardiovascular Quality and Outcomes 12 (2), e004973, 2019 | 54 | 2019 |
| Placental growth factor deficiency is associated with impaired cerebral vascular development in mice RL Luna, VR Kay, MT Rätsep, K Khalaj, M Bidarimath, N Peterson, ... MHR: Basic science of reproductive medicine 22 (2), 130-142, 2016 | 54 | 2016 |
| Brainstem neurons survive the identical ischemic stress that kills higher neurons: insight to the persistent vegetative state CD Brisson, YT Hsieh, D Kim, AY Jin, RD Andrew PloS one 9 (5), e96585, 2014 | 54 | 2014 |
| Magnetic resonance molecular imaging of post‐stroke neuroinflammation with a P‐selectin targeted iron oxide nanoparticle AY Jin, UI Tuor, D Rushforth, R Filfil, J Kaur, F Ni, B Tomanek, PA Barber Contrast media & molecular imaging 4 (6), 305-311, 2009 | 53 | 2009 |
| Characterization of Patients with Embolic Strokes of Undetermined Source in the NAVIGATE ESUS Randomized Trial Journal of Stroke and Cerebrovascular Diseases 27 (6), 1673-1682, 2018 | 46 | 2018 |
| Home virtual visits for outpatient follow-up stroke care: cross-sectional study R Appireddy, S Khan, C Leaver, C Martin, A Jin, BA Durafourt, SL Archer Journal of medical Internet research 21 (10), e13734, 2019 | 45 | 2019 |
| Good is not good enough: the benchmark stroke door-to-needle time should be 30 minutes N Kamal, O Benavente, K Boyle, B Buck, K Butcher, LK Casaubon, R Côté, ... Canadian Journal of Neurological Sciences 41 (6), 694-696, 2014 | 43 | 2014 |
| Robotic exoskeleton assessment of transient ischemic attack L Simmatis, J Krett, SH Scott, AY Jin PloS one 12 (12), e0188786, 2017 | 37 | 2017 |
| Heart, and Stroke Foundation Canada Canadian Stroke Best Practices Advisory Committee. Canadian stroke best practice recommendations: secondary prevention of stroke guidelines … SB Coutts, TH Wein, MP Lindsay, B Buck, R Cote, P Ellis, N Foley, MD Hill, ... Int J Stroke 10 (3), 282-91, 2015 | 35 | 2015 |
Andrew DemchukCalgary Stroke Program, Department of Clinical Neurosciences, Department of Radiology, HotchkissVerified email at ucalgary.ca
